13F-HR filed by Octagon Capital Advisors LP
Octagon Capital Advisors LP filed this 13F-HR for the quarter ended 2024-12-31, filed 2025-02-14, with 33 holding rows worth $607,700,826.
- Accession
- 0001839435-25-000002
- Filer
- CIK 1839435
- Filed
- 2025-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2024
A holdings report, 33 entries on the cover page, a total value of $607,700,826 stated on the cover page (in dollars after the unit check, H1), rows summing to $607,700,826 with VALUE read as dollars as filed, 13F file number 028-20958. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 3,006,980 | $95,952,732 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 2,059,387 | $54,862,070 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 2,110,167 | $46,001,641 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,993,052 | $33,383,621 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 571,264 | $26,529,500 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 9,202,907 | $24,479,733 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 332,000 | $22,921,280 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,763,000 | $21,551,400 | dollars as filed | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 488,000 | $21,091,360 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 3,018,000 | $21,005,280 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 2,425,000 | $20,709,500 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 10,450,000 | $18,078,500 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 250,000 | $17,260,000 | dollars as filed | call |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 870,000 | $16,677,900 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 18,350,000 | $16,599,410 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 668,000 | $15,738,080 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 778,000 | $14,914,260 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 1,115,000 | $13,157,000 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 308,000 | $12,951,400 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 5,136,795 | $12,893,355 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 441,600 | $12,117,504 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 904,000 | $11,950,880 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,370,000 | $11,603,900 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 10,000,000 | $7,942,000 | dollars as filed | |
| REGULUS THERAPEUTICS INC | 75915K309 | COM | 4,848,802 | $7,661,107 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 2,304,752 | $7,352,159 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 303,000 | $6,926,580 | dollars as filed | |
| ALLOVIR INC | 019818202 | COM | 11,215,000 | $4,710,300 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 900,000 | $3,258,000 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 250,000 | $2,625,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 152,000 | $2,546,000 | dollars as filed | put |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 992,000 | $1,418,560 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 312,336 | $830,814 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001839435-25-000002 | this filing | 2025-02-14 | acceptance time not in the bulk data set |